← back to search

Monika Hämmerle

Martin Luther University Halle-Wittenberg · DE
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cancer-related molecular mechanisms research, RNA modifications and cancer, Cancer, Hypoxia, and Metabolism, and Neuroblastoma Research and Treatments.
h-index
11
citations
4,688
works
43
NIH funding
primary concept
email

Recent publications

IGF2BP1 induces neuroblastoma via a druggable feedforward loop with MYCN promoting 17q oncogene expression
Molecular Cancer 2023cited by 43position: middledoi
Insulin-Like Growth Factor 2 mRNA-Binding Protein 1 (IGF2BP1) Is an Important Protumorigenic Factor in Hepatocellular Carcinoma
Hepatology 2014cited by 198position: middledoi
MALAT1 — a paradigm for long noncoding RNA function in cancer
Journal of Molecular Medicine 2013cited by 740position: middledoi
Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients
Hepatology 2013cited by 442position: middledoi
Posttranscriptional destabilization of the liver-specific long noncoding RNA HULC by the IGF2 mRNA-binding protein 1 (IGF2BP1)
Hepatology 2013cited by 242position: firstdoi
Abstract 1121: The long non-coding RNA MALAT1 is an essential gene regulator for lung cancer metastasis in a novel human knockout model .
Cancer Research 2013cited by 1position: middledoi
Abstract 1824: The non-coding RNA landscape of lung, liver and breast cancer reveals novel tumor-associated ncRNAs, concerted regulation and unexpected tissue specificity.
Cancer Research 2013cited by 0position: middledoi
The Noncoding RNA <i>MALAT1</i> Is a Critical Regulator of the Metastasis Phenotype of Lung Cancer Cells
Cancer Research 2012cited by 1,567position: middledoi
Loss of the abundant nuclear non-coding RNA<i>MALAT1</i>is compatible with life and development
RNA Biology 2012cited by 393position: middledoi
Abstract A21: MALAT-1 is essential for lung cancer metastasis in a novel human knockout model
Cancer Research 2012cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Sven Diederichs · University of Freiburg9 papers (2012–2014)Tony Gutschner · Luther University8 papers (2012–2014)Matthias Groß · University of Augsburg5 papers (2012–2013)Moritz F. Eissmann · La Trobe University4 papers (2012–2013)Martin Zörnig · Georg Speyer Haus4 papers (2012–2013)Kai Breuhahn · Heidelberg University3 papers (2013–2014)Thomas Longerich · German Cancer Research Center3 papers (2013–2014)Marion Stentrup · German Cancer Research Center3 papers (2012–2013)Peter Schirmacher · Kliniken Essen-Mitte3 papers (2012–2014)Alexey S. Revenko · Ionis Pharmaceuticals (United States)2 papers (2012–2013)Jeff Hsu · University of California, Los Angeles2 papers (2012–2013)Hannah J. Uckelmann · Goethe University Frankfurt2 papers (2013–2014)Evgenij Fiškin · Broad Institute2 papers (2013–2014) · 2 papers (2014–2023)Gayatri Arun · Long Island University2 papers (2012–2013)Britta Skawran · Medizinische Hochschule Hannover2 papers (2013–2014)Stefan Hüttelmaier · Martin Luther University Halle-Wittenberg2 papers (2014–2023)Robert Geffers · Imperial College London2 papers (2013–2014)Gene Hung · Ionis Pharmaceuticals (United States)2 papers (2012–2013)David L. Spector · Harvard University2 papers (2012–2013)